Dasatinib in core‐binding factor acute myeloid leukemia: A promising therapeutic approach

Authors

Institutions

Publication Details

Journal
eJHaem
Published
2024-08-19
DOI
https://doi.org/10.1002/jha2.994
Citations
1
Primary Topic
Chronic Myeloid Leukemia Treatments
Type
article
Field-Weighted Citation Impact
0.45
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dasatinib in core‐binding factor acute myeloid leukemia: A promising therapeutic approach

Shyam Srinivasan
1 citations
eJHaem
Chronic Myeloid Leukemia Treatments
0.45
article

Dasatinib in core‐binding factor acute myeloid leukemia: A promising therapeutic approach

Shyam Srinivasan
article en
1 citations

Abstract

No abstract available for this paper.
eJHaemVol. 5(5)
Homi Bhabha National Institute (IN), Tata Memorial Hospital (IN)
Zero hunger
Openalex Percentile: Top 34%
Chronic Myeloid Leukemia Treatments
0.45
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Dasatinib in core‐binding factor acute myeloid leukemia: A promising therapeutic approach — Shyam Srinivasan · eJHaem (2024) | TGRS Research Map | TGRS